Theragene Pharmaceuticals, Inc. — Form D
Theragene Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-11. The offering totals $30.0M, of which $200K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-08-11
- Form: D
- Accession: 0001078782-15-001259
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $200K
- Remaining: $29.8M
- Minimum investment: $200K
- Investors: 1
- Date of first sale: 2015-07-27
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-245513
Issuer
- Name: Theragene Pharmaceuticals, Inc.
- CIK: 0001601923
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2011
- Address: 11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA, 92121
- Phone: 619-788-2383
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jon Berglin | Director | San Diego, CA |
| Daniel Coury | Director | San Diego, CA |
| Steven Davis | Director | Boston, MA |
| Chaojie Zhang | Director | San Diego, CA |
| Jon Berglin | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More